Medicine Experts

Eyvind Jakob Paulssen

Department of Clinical Medicine
University of Tromso


Cand. Med., University of Oslo, 1985;Dr. med., University of Oslo, 1992;Specialist in Internal Medicine and Digestive Diseases 2001;Associate Professor II, IKM 2006-2010;Professor II, IKM, 2010 -

Research Interest

Digestive diseases, including infectious hepatitis, inflammatory bowel disease, obesity and its complications.


  • Olsen T, Rismo R, Gundersen MD, Paulssen EJ, Johnsen K, Kvamme JM, Goll R, Florholmen J. Normalization of mucosal tumor necrosis factor-α: A new criterion for discontinuing infliximab therapy in ulcerative colitis. Cytokine. 2016 Mar 31;79:90-5.

  • Johnsen KM, Goll R, Hansen V, Olsen T, Rismo R, Heitmann R, Gundersen MD, Kvamme JM, Paulssen EJ, Kileng H, Johnsen K. Repeated intensified infliximab induction–results from an 11-year prospective study of ulcerative colitis using a novel treatment algorithm. European journal of gastroenterology & hepatology. 2017 Jan 1;29(1):98-104.

Global Experts from Rwanda

Global Experts in Subject

Share This Profile
Recommended Conferences